Crosstalks

24/10/2013 - Active and Healthy Aging: Shaping Health and Supporting Frailty

Info

Date: 
24 Oct 2013
Place: 

ICAB, Witte Patersstraat 4, 1040 Brussel, Room MADERA

The Crosstalks project Healthy and Active aging starts from an interdisciplinary and holistic approach that addresses both mental and physical health to stimulate the independence and well-being of older people. Supporting frailty therefore requires strategies that go beyond clinical issues, as part of a wide range of services to their needs. This workshop captures the different aspects of frailty with elderly people.

Programme: 

Session chairs: Alain Dupont (VUB) & Pascale Cornette (UCL)

13.30-14.00: Registration, coffee & welcome
14.00-14.10: Introduction & Context
14.10-14.40: Jean-Luc Balligand (Université Catholique de Louvain) : Statin therapy and the elderly: mechanisms and risks
14.40-14:50: Q&A
14:50-15.20: Tony Mets (UZ VUB, Geriatry): The concepts of frailty
15.20-15.45: Q&A
15.45-16.15: Coffee & Tea break
16.15-16.45: Arto Strandberg (University of Helsinki, FI): Biomedical frailty
16:45-17:30: Closing discussion with speakers and participants

 

Registration

Registration has been closed

Bios / Slides

Jean-Luc Balligand and his team developed the core of their research projects in the biochemistry and cellular biology of nitric oxide synthases (NOS) including their regulation in cardiovascular tissues. His group initiated the research on the role of NOS in cardiac myocyte contractility which is being extended in the context of myocardial remodelling and regeneration, e.g. in response to neurohormones and adrenoceptors. His lab has recognized expertise in cell signalling and cardiovascular pharmacology using in vitro and in vivo models. JL Balligand is Head of the FATH Pole within IREC and also practicing Physician at the Cliniques Universitaires Saint-Luc, UCL and teaches cardiovascular physiology and pharmacology at UCL Medical School.
More recently, JL Balligand has developed these research directions as associated partner of a Leducq Foundation-funded transatlantic network of excellence in cardiovascular sciences and of of the FP6-EUGeneHeart consortium that laid the ground for innovative research in therapeutics for heart failure. He also coordinates several collaborative programmes (Concerted Actions, Interuniversity Attraction Pole) funded by the Politique Scientifique Fédérale.
J-L Balligand is a Board member of the ESC Council on Basic Cardiovascular Science and has been co-director of the Summer School in Basic Cardiovascular Research sponsored by the Council since 2009. Since September 2009, Prof Balligand is also Vice-President of BioWin, the Health Sciences cluster of Wallonia that promotes translational innovative research in partnership with biomedical industries (cfr. Insight in Nature, Sept 6, 2012).

Pascale Cornette is geriatrician and head of the geriatric department of Saint-Luc university hospital (Université catholique de Louvain). Her PhD, in 2006, focused on older patients in emergency unit and identfication of risk of hospital-associated functional decline. More recently, she also developped interest in onco-geriatrics.

Alain Dupont, MD, PhD, an internist and certified clinical pharmacologist, is full professor and head of the Department of Pharmacology at the Vrije Universiteit Brussel, and head of the department of Clinical Pharmacology and Pharmacotherapy at the University Hospital UZ Brussel, where he also runs a hypertension clinic. He has been Vice-Dean Research and is currently Dean of the Faculty of Medicine and Pharmacy. Dupont is a member and was the founding president of the Belgian Commission for Reimbursement of Medicines. His research activities, mainly in the fields of hypertension and cardio-vascular pharmacology, resulted in 3 prizes, over 120 publications in peer reviewed journals as well as several chapters in books. He chairs the Accompanying Committee of CROSSTALKS.

Tony Mets (MD, PhD) is specialist in Internal Medicine and Geriatrics and emeritus professor in Gerontology and Geriatrics at the Vrije Universiteit Brussel (VUB). His research is focused on the domain of clinical medicine (frailty, sarcopenia, dementia, inflammation) and mechanisms of aging (cellular senescence).

Arto Y Strandberg became M.D. at the medical faculty of the Helsinki University in 1982 and obtained a Ph.D. at the same university in 2010. He worked as general practitioner at the Aava Medical Center, in Kerava, Finland and as clinical researcher affiliated at the Department of Medicine, Geriatric Clinic, University of Helsinki, Finland. Since 2002 he is a member of the Helsinki Businessmen Study group, a longitudinal study on ageing. Strandberg wrote over 20 papers in peer-reviewed journals including Archives of Internal Medicine (JAMA Internal Medicine), Journal of Gerontology, Journal of the American Geriatrics Society, American Journal of Epidemiology, and Annals of Medicine. His primary research interest has been on the effect of midlife risk factors on quality of life in late life and successful ageing. His academic dissertation at the University of Helsinki, published in 2010, can be read online .

 

Presentation by Jean-Luc Balligand

Presentation by Tony Mets

Presentation by Arto Strandberg